These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3971389)

  • 1. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
    Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of ascorbic acid on the free-radical metabolism of xenobiotics: the example of diaziquone.
    Gutierrez PL
    Drug Metab Rev; 1988; 19(3-4):319-43. PubMed ID: 3068033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sister chromatid exchange induction by diaziquone in human and mouse lymphocytes following both in vivo and in vitro exposures.
    Kligerman AD; Erexson GL; Bryant MF
    Cancer Res; 1988 Jan; 48(1):27-31. PubMed ID: 3334997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photosensitization of leukemia L1210 cells with diaziquone.
    Kessel D; Thompson P
    Cancer Res; 1986 Nov; 46(11):5587-8. PubMed ID: 3756904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
    Gutierrez PL; Biswal S; Nardino R; Biswal N
    Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
    Ngo EO; Nutter LM; Sura T; Gutierrez PL
    Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB; Cadenas E
    Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
    Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
    Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of correlation between toxicity and free radical formation of two diaziridinyl benzoquinones.
    Lea JS; Garner HJ; Butler J; Hoey BM; Ward TH
    Biochem Pharmacol; 1988 May; 37(10):2023-5. PubMed ID: 2837220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron spin resonance of electrochemically generated free radicals from diaziquone and its derivatives.
    Gutierrez PL; Fox BM; Mossoba MM; Egorin MJ; Nakazawa H; Bachur NR
    Biophys Chem; 1985 Jun; 22(1-2):115-23. PubMed ID: 2992620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of phytohemagglutinin isolectins L4 and E4 on L1210 cells.
    Egorin MJ; Odders RN; Sanel FT; Felsted RL; Bachur NR
    Cancer Res; 1978 Jun; 38(6):1677-87. PubMed ID: 565679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adducts of the antitumor agent diaziquone.
    Gupta RC; Garg A; Earley K; Agarwal SC; Lambert GR; Nesnow S
    Cancer Res; 1991 Oct; 51(19):5198-204. PubMed ID: 1913643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cytotoxicity of diaziquone toward Chinese hamster ovary cells under hypoxic and aerobic exposure conditions.
    O'Brien PJ; Kaul HK; Rauth AM
    Cancer Res; 1990 Mar; 50(5):1516-20. PubMed ID: 2302714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.
    Oberc-Greenwood MA; Smith BH; Cooke C; Ellis JR; Kornblith PL; McKeever PE
    J Natl Cancer Inst; 1983 Oct; 71(4):725-33. PubMed ID: 6578368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactosyltransferase activity and cell growth: uridine diphosphate (UDP)galactose inhibition of murine leukemic L1210 cells.
    Klohs WD; Wilson JR; Weiser MM; Frankfurt O; Bernacki RJ
    J Cell Physiol; 1984 Apr; 119(1):23-8. PubMed ID: 6423650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.